A gastroenterologist at the Mayo Clinic who treats patients with colorectal cancer shares the warning signs of the disease he'd look for in his own body.

After getting engaged, the only words journalist Mrinali Dhembla expected to hear were “I do.” Instead, she was told, “You ...

Colorectal cancer is the third most common cancer in the United States. Although screening has led to a decrease in incidence over the past 20 years, early-onset colorectal cancer has been rising.

Underinvested, Under-Referred, and Underserved: Applying a Gender Equity Continuum Framework in Cancer Control Continuum Programs and Policies to Expand to Transgender and Nonbinary Populations Of 336 ...

An advanced cancer diagnosis didn't stop this 26-year-old from finding humor as she went through treatment.

Neoadjuvant treatment with a programmed cell death 1 (PD-1) inhibitor induces clinical complete response and leads to organ preservation in a high proportion of patients with early-stage, mismatch ...

Intuition is what prompted Colleen McGarrity to get a colonoscopy at age 41. The preventative screening probably saved her life. The Ford City resident experienced spotty symptoms but had no family ...

Shannon Ivey was 42 and a single mom when she was diagnosed with Stage 3 rectal cancer. She reveals the symptoms she mistook ...

Colorectal cancer is often spoken of as a single disease, but it actually refers to two related cancers: colon cancer and rectal cancer. The latter was recently revealed as the reason we lost the ...

Use of a neoadjuvant checkpoint inhibitor enabled a high proportion of patients with early-stage mismatch repair-deficient (dMMR) solid tumors to avoid surgery and achieve organ preservation in a ...

Dostarlimab treatment led to complete clinical responses in 82% of patients with dMMR tumors, avoiding surgery for most. Recurrence-free survival at two years was 92%, with a median follow-up of 20 ...